HM
SAGE

Harvest Management’s Sage Therapeutics SAGE Stock Holding History

Harvest Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-889,200
Closed -$8.11M – 91
2025
Q2 		$8.11M Buy
889,200
+163,000
+22% +$1.2M 3.45% 7
2025
Q1 		$5.77M Buy
+726,200
New +$5.32M 2.55% 12

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Harvest Management's SAGE Position: Q3 2025 in Review

Harvest Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 889,200 shares — an estimated $8.11M sold.

Harvest Management first reported a position in SAGE in Q1 2025 and held it in 2 quarters. The position peaked at $8.11M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Harvest Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Harvest Management sold 889,200 Sage Therapeutics shares in Q3 2025, an estimated $8.11M.
  • Harvest Management first reported a position in Sage Therapeutics in Q1 2025 and held it in 2 quarters.
  • Harvest Management's Sage Therapeutics position peaked at $8.11M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Harvest Management's 13F filing for Q3 2025, filed 14 Nov 2025.